Clinical trial
Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot…
NCT00035386 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00035386 |
|---|---|
| Title | Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study |
| Official title | Trans-Right Ventricular Approach to Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Feasibility Study |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertrophic Cardiomyopathy |
| Intervention type | Procedure |
| Interventions | trans-right ventricular alcohol septal ablation (TRVASA) |
| Enrollment | 12 |
| Start date | Apr 1, 2002 |
| Completion | Apr 1, 2003 |
| First posted | May 3, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: